Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Elise, Poulhazan"'
Autor:
Steve Raoul Noumegni, Raphael Le Mao, Claire de Moreuil, Clément Hoffmann, Emmanuelle Le Moigne, Cécile Tromeur, Vincent Mansourati, Bahaa Nasr, Jean-Christophe Gentric, Marie Guegan, Elise Poulhazan, Luc Bressollette, Karine Lacut, Romain Didier, Francis Couturaud
Publikováno v:
Chest. 162:1147-1162
Autor:
Steve Raoul Noumegni, Vincent Mansourati, Cécile Tromeur, Raphael Le Mao, Clément Hoffmann, Emmanuelle Le Moigne, Bahaa Nasr, Jean-Christophe Gentric, Marie Guegan, Elise Poulhazan, Luc Bressollette, Karine Lacut, Francis Couturaud, Romain Didier
Publikováno v:
Thrombosis and Haemostasis. 122:1744-1756
Background Cardiovascular deaths (CVDTs) are more frequent in patients with venous thromboembolism (VTE) than in the general population; however, risk factors associated with this increased risk of CVDT in patients with VTE are not described. Methods
Autor:
Steve Raoul Noumegni, Romain Didier, Vincent Mansourati, Emmanuelle Le Moigne, Raphael Le Mao, Clément Hoffmann, Claire De Moreuil, Cécile Tromeur, Pierre-Yves Le Roux, Bahaa Nasr, Jean-Christophe Gentric, Marie Guegan, Elise Poulhazan, Karine Lacut, Luc Bressollette, Francis Couturaud
Publikováno v:
Seminars in Thrombosis and Hemostasis. 48:465-480
Background There is an increased risk of arterial events including major adverse cardiovascular events (MACE) and major adverse limb events (MALE) after venous thromboembolism (VTE). However, their risk factors remain little explored.Methods We aimed
Autor:
Steve Raoul, Noumegni, Romain, Didier, Vincent, Mansourati, Cécile, Tromeur, Emmanuelle, Le Moigne, Clément, Hoffmann, Bahaa, Nasr, Jean-Christophe, Gentric, Marie, Guegan, Elise, Poulhazan, Karine, Lacut, Luc, Bressollette, Raphael, Le Mao, Francis, Couturaud
Publikováno v:
Thrombosis Research. 214:93-105
The increased risk of arterial thrombotic (ATE) after VTE, particularly when they are unprovoked or cancer-associated has been established. However, the risk factors of ATE after these VTE remain unclear.Using cause-specific hazard regression models,
Autor:
Steve Raoul Noumegni, Cécile Tromeur, Clément Hoffmann, Raphael Le Mao, Emmanuelle Le Moigne, Claire de Moreuil, Vincent Mansourati, Bahaa Nasr, Jean-Christophe Gentric, Marie Guegan, Elise Poulhazan, Luc Bressollette, Karine Lacut, Romain Didier, Francis Couturaud
Publikováno v:
Seminars in Thrombosis and Hemostasis.
After first episodes of venous thromboembolism (VTE), patients are at increased risk of recurrent VTE and arterial thrombotic events (ATE) compared with the general population, two disorders that are influenced by anticoagulation. However, risk facto
Autor:
Xavier Savary, Elise Poulhazan, Brigitte Pan-Petesch, Clément Hoffmann, Marie Guegan, Karine Lacut, Emmanuelle Le Moigne, Raphael Le Mao, Michel Nonent, Pierre-Yves Salaun, Marc Danguy des Déserts, Christophe Leroyer, Cécile Tromeur, Claire de Moreuil, Francis Couturaud
Publikováno v:
European Journal of Internal Medicine. 84:24-31
Data on long-term venous thromboembolism (VTE) recurrence risk according to gender are conflicting.To evaluate long-term VTE recurrence risk after a first VTE in men and women under 50 years old.Since May 2000, 875 consecutive patients (315 men, 560
Autor:
Pierre-Yves Le Roux, Luc Bressollette, Marie Guegan, Karine Lacut, Raphael Le Mao, Christophe Leroyer, Pierre-Yves Salaun, Charles Orione, Michel Nonent, Catherine A. Lemarié, Pierre-Yves Le Floch, Elise Poulhazan, Cécile Tromeur, Francis Couturaud, Clément Hoffmann, Philippe Robin
Publikováno v:
Thrombosis and Haemostasis. 121:955-963
Background We aimed to assess whether high pulmonary vascular obstruction index (PVOI) measured at the time of pulmonary embolism (PE) diagnosis is associated with an increased risk of recurrent venous thromboembolism (VTE). Study Design and Methods
Autor:
Steve Raoul, Noumegni, Raphael, Le Mao, Claire, de Moreuil, Clément, Hoffmann, Emmanuelle, Le Moigne, Cécile, Tromeur, Vincent, Mansourati, Bahaa, Nasr, Jean-Christophe, Gentric, Marie, Guegan, Elise, Poulhazan, Luc, Bressollette, Karine, Lacut, Romain, Didier, Francis, Couturaud
Publikováno v:
Chest. 162(5)
It was recently established that patients who developed VTE are at increased risk of major adverse cardiovascular events (MACE) compared with the general population. However, whether the anticoagulation used for VTE influences the risk of MACE remain
Autor:
I. Frachon, M.-R. Munck, A. Dirou, D. Horeau-Langlard, M.-P. Pelletier, Christopher Payan, I. Danner-Boucher, J. Caillon, G. Le Gal, Gilles Rault, J. Le Bihan, Sylvain Rosec, S. Ramel, Claude Férec, Elise Poulhazan, Emmanuel Nowak, Geneviève Héry-Arnaud, K. Revert, A. Haloun, S. Gouriou, R. Le Berre, V. David
Publikováno v:
Clinical Microbiology and Infection
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2017, 23 (3), pp.203-207
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2017, 23 (3), pp.203-207
Objectives Early detection of Pseudomonas aeruginosa lung positivity is a key element in cystic fibrosis (CF) management. PCR has increased the accuracy of detection of many microorganisms. Clinical relevance of P. aeruginosa quantitative PCR (qPCR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5f414f78134eef6ecc0918ba4e4cb0
https://hal.univ-brest.fr/hal-02048694
https://hal.univ-brest.fr/hal-02048694
Autor:
Grégoire Le Gal, Thomas Lemaitre, Jean-Michel Roué, Elise Poulhazan, Emmanuel Nowak, Emmanuel Oger, Jean-Dominique Giroux, Armelle Garenne, Arnaud Gagneur
Publikováno v:
Clinical and Vaccine Immunology
Clinical and Vaccine Immunology, American Society for Microbiology, 2014, 21 (10), pp.1404--1409. ⟨10.1128/CVI.00265-14⟩
Clinical and Vaccine Immunology, American Society for Microbiology, 2014, 21 (10), pp.1404--1409. ⟨10.1128/CVI.00265-14⟩
Infants born preterm are at a higher risk of complications and hospitalization in cases of rotavirus diarrhea than children born at term. We evaluated the impact of a rotavirus vaccination campaign (May 2007 to May 2010) on hospitalizations for rotav